AstraZeneca’s (AZN) Hold Rating Reiterated at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft reissued their hold rating on shares of AstraZeneca (LON:AZN – Free Report) in a research note released on Tuesday morning,Digital Look reports. The firm currently has a £117 target price on the biopharmaceutical company’s stock. Several other analysts have also recently issued reports on the stock. Berenberg Bank lowered their target price […]
2 Oct 05:06 · The Markets Daily